Larry C. Lands, M.D., PhD
Affiliations: | McGill University, Montreal, QC, Canada |
Google:
"Larry Lands"Parents
Sign in to add mentor| Pierre Beaudry | fellowship/program director | 1986 | Montreal Children's Hospital |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hebestreit H, Hulzebos EH, Schneiderman JE, et al. (2018) Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine |
| Hebestreit H, Lands LC, Alarie N, et al. (2018) Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): study protocol. Bmc Pulmonary Medicine. 18: 31 |
| Radtke T, Hebestreit H, Gallati S, et al. (2017) CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study. Annals of the American Thoracic Society |
| De Boeck K, Haarman E, Hull J, et al. (2017) Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
| Mailhot G, Dion N, Farlay D, et al. (2017) Impaired rib bone mass and quality in end-stage cystic fibrosis patients. Bone. 98: 9-17 |
| Hebestreit H, Hulzebos E, Schneiderman J, et al. (2017) WS08.6 Cardiopulmonary exercise testing provides additional prognostic information in people with cystic fibrosis Journal of Cystic Fibrosis. 16: S15 |
| Matouk E, Nguyen D, Benedetti A, et al. (2016) C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations. Journal of Pulmonary & Respiratory Medicine. 6: 1000375 |
| Mak DY, Sykes J, Stephenson AL, et al. (2016) The benefits of newborn screening for cystic fibrosis: The Canadian experience. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
| Lands LC, Stanojevic S. (2016) Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. The Cochrane Database of Systematic Reviews. 4: CD001505 |
| Radtke T, Hebestreit H, Gallati S, et al. (2016) LATE-BREAKING ABSTRACT: Aerobic exercise capacity in cystic fibrosis – Does CFTR genotype matter? European Respiratory Journal. 48 |